bioRxivEvolutionary Biology
Reproduction and longevity A Mendelian randomization study of gonadotropin-releasing hormone and ischemic heart disease
Abstract
BackgroundAccording to well-established evolutionary biology theory reproduction trades-off against longevity, implying that upregulating the reproductive axis might drive major diseases. We assessed whether the central driver of reproduction gonadotropin-releasing hormone 1 (GnRH1) had a causal effect on the leading cause of global morbidity and mortality, i.e. ischemic heart disease (IHD). As a contrast we similarly examined the role of GnRH2 because it is more a driver of female sexual behavior.\n\nMethodsWe applied strong (p-value <5x10-6) and independent genetic predictors of GnRH1 and GnRH2 to an extensively genotyped IHD case (n=76,014) - control (n=264,785) study using multiplicative random effects inverse variance weighted (IVW), weighted median, MR-Egger and MR-PRESSO estimates.\n\nResultsGnRH1, predicted by 11 genetic variants, was positively associated with IHD (IVW odds ratio (OR) 1.04 per effect size, 95% confidence interval (CI) 1.01 to 1.08), but GnRH2, predicted by 15 genetic variants, was not (IVW OR 0.98, 95% CI 0.95 to 1.02).\n\nConclusionsGnRH1 is a potential IHD genetic target. Apart from demonstrating a central tenet of evolutionary biology in humans, our study suggests that existing treatments and environmental factors targeting GnRH1, its drivers or consequences could be re-purposed to prevent and treat IHD. Given, the importance of reproduction to the human species, many such exposures likely exist.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Apolipoprotein B and Interleukin 1 Receptor Antagonist: Reversing the Risk of Coronary Heart Disease
Fangkun Yang, Ning Huangfu, … Shuai Yuan·Frontiers in EndocrinologyPeer-reviewed·Oct 24, 2023
- GLP1R expression protects against 58 diseases but raises risk for 34 diseases and neonatal health
Robert H Campbell, Melinda C Mills·medRxiv·Feb 18, 2026
- Associations of endogenous and exogenous hormonal exposures and cardiovascular disease in women - A FinnGen study
Tia-Marje K. Korhonen, Takiy-Eddine Berrandou, … Eija K. Laakkonen·medRxiv·Mar 14, 2026
- Human genetics suggests differing causal pathways from HMGCR inhibition to coronary artery disease and type 2 diabetes
Seongwon Hwang, Ville Karhunen, … Stephen Burgess·International Journal of EpidemiologyPeer-reviewed·Dec 25, 2025
- GWAS identifies novel risk locus for erectile dysfunction and implicates hypothalamic neurobiology and diabetes in etiology
Jonas Bovijn, Leigh M. Jackson, … Michael Vaclav Holmes·The American Journal of Human GeneticsPeer-reviewed·Dec 21, 2018
- Exploring repositioning opportunities and side-effects of statins: a Mendelian randomization study of HMG-CoA reductase inhibition with 55 complex traits
Hon‐Cheong So, Carlos Kwan‐Long Chau, Kai Zhao·bioRxiv·Dec 23, 2017